<VariationArchive VariationID="1805338" VariationName="NM_006766.5(KAT6A):c.3377del (p.Ser1126fs)" VariationType="Deletion" Accession="VCV001805338" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-23" DateCreated="2022-12-24" MostRecentSubmission="2022-12-24">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1862350" VariationID="1805338">
      <GeneList>
        <Gene Symbol="KAT6A" FullName="lysine acetyltransferase 6A" GeneID="7994" HGNC_ID="HGNC:13013" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>8p11.21</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="41929479" stop="42051987" display_start="41929479" display_stop="42051987" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="41786996" stop="41909504" display_start="41786996" display_stop="41909504" Strand="-" />
          </Location>
          <OMIM>601408</OMIM>
          <Haploinsufficiency last_evaluated="2018-03-28" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=KAT6A">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2018-03-28" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=KAT6A">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_006766.5(KAT6A):c.3377del (p.Ser1126fs)</Name>
      <CanonicalSPDI>NC_000008.11:41934842:G:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>8p11.21</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="41934843" stop="41934843" display_start="41934843" display_stop="41934843" variantLength="1" positionVCF="41934842" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="41792361" stop="41792361" display_start="41792361" display_stop="41792361" variantLength="1" positionVCF="41792360" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>S1126fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.10" sequenceAccession="NC_000008" sequenceVersion="10" change="g.41792361del" Assembly="GRCh37">
            <Expression>NC_000008.10:g.41792361del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.11" sequenceAccession="NC_000008" sequenceVersion="11" change="g.41934843del" Assembly="GRCh38">
            <Expression>NC_000008.11:g.41934843del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_042093.1" sequenceAccession="NG_042093" sequenceVersion="1" change="g.122184del">
            <Expression>NG_042093.1:g.122184del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006766.5" sequenceAccession="NM_006766" sequenceVersion="5" change="c.3377del" MANESelect="true">
            <Expression>NM_006766.5:c.3377del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_006757.2" sequenceAccession="NP_006757" sequenceVersion="2" change="p.Ser1126fs">
            <Expression>NP_006757.2:p.Ser1126fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_006766.5(KAT6A):c.3377del (p.Ser1126fs) AND Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome" Accession="RCV002471756" Version="1">
        <ClassifiedConditionList TraitSetID="20960">
          <ClassifiedCondition DB="MedGen" ID="C4225396">Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-10-19" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2020-10-19" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-12-24" MostRecentSubmission="2022-12-24">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">25728777</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="20960" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="33036" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Arboleda-Tham syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mental retardation, autosomal dominant 32</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome</ElementValue>
                <XRef ID="MONDO:0014558" DB="MONDO" />
                <XRef ID="457193" DB="Orphanet" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">KAT6A syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ARTHS</ElementValue>
                <XRef Type="MIM" ID="616268" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17797" />
                <XRef ID="17797" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="457193" DB="Orphanet" />
              <XRef ID="C4225396" DB="MedGen" />
              <XRef ID="MONDO:0014558" DB="MONDO" />
              <XRef Type="MIM" ID="616268" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5413569" SubmissionDate="2022-12-21" DateLastUpdated="2022-12-24" DateCreated="2022-12-24">
        <ClinVarSubmissionID localKey="vcgs/unit_1/hg38_NM_006766_4_KAT6A_c_3377delC" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002766664" DateUpdated="2022-12-24" DateCreated="2022-12-24" Type="SCV" Version="1" SubmitterName="Victorian Clinical Genetics Services, Murdoch Childrens Research Institute" OrgID="500104" OrganizationCategory="laboratory" OrgAbbreviation="VCGS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-10-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">25728777</ID>
          </Citation>
          <Comment>Based on the classification scheme VCGS_Germline_v1.1.1, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss-of-function is a known mechanism of disease for this gene. (N) 0107 - This gene is known to be associated with autosomal dominant disease. (N) 0204 - Variant is predicted to result in a truncated protein with more than 1/3 of the protein affected (exon 17 of 17). (P) 0251 - Variant is heterozygous. (N) 0301 - Variant is absent from gnomAD. (P) 0401 - Variant is located in a gene associated with a severe early-onset dominant condition that is intolerant to loss-of-function variants. (P) 0601 - Variant affects at least one well-established (essential) functional domain or motif. The variant is located within the transactivation domain which is essential for normal protein function (PMID: 25728777). (P) 0701 - Comparable variants have very strong previous evidence for pathogenicity. Other variants predicted to cause a truncated protein have been reported as pathogenic in ClinVar. (P) 0807 - Variant has not previously been reported in a clinical context. (N) 0905 - No segregation evidence has been identified for this variant. (N) 1007 - No published functional evidence has been identified for this variant. (N) 1204 - Variant shown to be de novo in proband (parental status not tested but assumed). (P) Legend: (P) - Pathogenic, (N) - Neutral, (B) - Benign</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KAT6A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_4644</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006766.4:c.3377delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0014558" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_38</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5413569" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0014558" MappingRef="MONDO">
        <MedGen CUI="C4225396" Name="Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

